09/30/2026
Clinical research plays a critical role in advancing potential treatment options for people living with Vascular Ehlers-Danlos syndrome (VEDS).
Our Phase 3 DiSCOVER study is evaluating an investigational treatment option for individuals diagnosed with VEDS, a rare genetic disorder that can affect blood vessels and organs.
If you or someone you know has been diagnosed with VEDS, learn more about eligibility and participating study locations.
Together, we can help advance research for the VEDS community: https://discoverceliprolol.com/